Tag Archive: Intellectual Property Rights

Drug Companies Looting SA’s bounty of Medicinal Plants

The government has stepped in to save a tiny South African plant from extinction after hundreds of tons were harvested for foreign drug companies, one of which has patented its use to fight HIV/Aids. Now traditional healers, who have used the plant for centuries, are trying to win back the patent which they claim is rightfully theirs.

read more

ACB Submission on IPRs from Publicaly Funded Research Bill, 2007

Currently, South African intellectual property legislation is highly fragmented, a situation that gives rise to a number of gaps and anomalies that undermine the rights of indigenous people. “Indigenous people” is not clearly defined by NEMBA or it Draft Regulations except to refer to such people as residing in a defined geographical area to which indigenous knowledge is found.

read more

BT-Maize 176 / SyngentaBt-Potato G2 & G3 / South African Agricultural Research Council

  • GMPotatoesObjection.pdf Additional Comments and Objections to Continued Trials of GM Potatoes

    African Centre for Biosafety, supported by various organisations, groups, companies, and individuals, Mar 2006

  • objection_bt_potato_g2_g3.pdf Objections to application for a permit for additional trials with insect resistant Bt Cry V Genetically Modified Potatoes (Solanum Tuberosum L. Variety ‘Spunta’ G2 and G3), as applied for by Dr G. Thompson, Director Plant Protection and Biotechnology , South African Agricultural Research Council, dated 24 May 2004 Download 157Kb

    G. Ashton, G. Baker, M. Mayet, E. Pschorn-Strauss, W. Stafford, June 2004

  • Report2_Bt_Potato_G2G3.pdf Report 2003/2004 GMO Potato Project.

    ARC-Roodeplaat, Vegetable and Ornamental Plant Institute and the Michigan State University (USA), made public in June 2004
    Download 156Kb


1 Rights of Access to information severely prejudiced

The extensive deficiencies in the information supplied by the Applicant in response to our request for access to information in terms of the Promotion of Access to Information Act, 2000 (“PAIA”) coupled with the conflicting time frames provided by the Regulations under the Genetically Modified Organisms Act 15 of 1997 (“GMO Act” and those provided by PAIA, have severely restricted our rights to access